Literature DB >> 22843651

'Overdiagnosis' and mortality in breast cancer screening.

Ann Johnson1.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22843651      PMCID: PMC3407398          DOI: 10.1258/jrsm.2012.120003

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Observations on growth rates of human tumors.

Authors:  V P COLLINS; R K LOEFFLER; H TIVEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1956-11

2.  Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.

Authors: 
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

Review 3.  The breast screening programme and misinforming the public.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  J R Soc Med       Date:  2011-09       Impact factor: 5.344

4.  Does breast cancer grade worsen with time? Evidence from breast screening.

Authors:  A Johnson; J Shekhdar
Journal:  Breast Cancer Res Treat       Date:  2001-08       Impact factor: 4.872

5.  Breast cancer incidence: what do the figures mean?

Authors:  Ann Johnson; Jane Shekhdar
Journal:  J Eval Clin Pract       Date:  2005-02       Impact factor: 2.431

6.  Interval cancers in the National Health Service Breast Screening Programme.

Authors:  A E Johnson; J Shekhdar
Journal:  Br J Radiol       Date:  1995-08       Impact factor: 3.039

Review 7.  Ductal carcinoma in situ: a proposal for a new classification.

Authors:  R Holland; J L Peterse; R R Millis; V Eusebi; D Faverly; M J van de Vijver; B Zafrani
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.